UPDATE
3-U.S. FDA
panel backs Amgen copy of
AbbVie arthritis drug Humira
July 12 (Reuters) -
Amgen Inc's cheaper version ofAbbVie's top-selling
arthritis drug Humira is highlysimilar to the original and should be approved, an advisorypanel to the U.S. Food and Drug...